Toshihiro Hashiguchi

Prognostic Value of Programmed Death Ligand 1 and Programmed Death 1 Expression in Thymic Carcinoma

Shintaro Yokoyama, Hiroaki Miyoshi, Kazutaka Nakashima et al. · Clinical Cancer Research · 2016 · 81 citations

Clinicopathologic and Prognostic Implications of Programmed Death Ligand 1 Expression in Thymoma

Shintaro Yokoyama, Hiroaki Miyoshi, Tatsuya Nishi et al. · The Annals of Thoracic Surgery · 2016 · 69 citations · Full text

Thyroid Disease, Immunology, Cell Death +8

Survival after initial lung metastasectomy for metastatic colorectal cancer in the modern chemotherapeutic era

Shintaro Yokoyama, Masahiro Mitsuoka, Tetsushi Kinugasa et al. · BMC Surgery · 2017 · 25 citations · Full text

GATA3 Expression Is a Poor Prognostic Factor in Soft Tissue Sarcomas

Toshiaki Haraguchi, Hiroaki Miyoshi, Koji Hiraoka et al. · PLoS ONE · 2016 · 23 citations · Full text

Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma

Toshihiro Hashiguchi, Hiroaki Miyoshi, Kazutaka Nakashima et al. · Human Pathology · 2017 · 21 citations

Primary Lung Adenocarcinoma, Tumor Biology, Prognostic Impact +12